group a streptococcus vaccine (alum)

**Group A streptococcus vaccine (alum)** is GSK's investigational four-component, peptide-based vaccine formulation for prevention of infection caused by *Streptococcus pyogenes* (group A streptococcus). The formulation contains four vaccine antigen components with aluminum hydroxide (alum) adjuvant and is designed to induce protective adaptive immune responses, including antibodies directed against Strep A antigens. It is being evaluated as one of two adjuvanted formulations in a first-in-human, randomized, placebo-controlled Phase 1 study in healthy adults aged 18–25 years, using low, medium, and high intramuscular dose levels. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07085702))

Other names

4-component Group A Streptococcus pyogenes vaccine with alum4-component Strep A vaccine with alumGSK 4-component vaccine against Group A Streptococcus pyogenes with alumGSK4-component vaccine against Group A Streptococcus pyogenes with alumGSK-4-component vaccine against Group A Streptococcus pyogenes with alumStrep A alum vaccine